$100.25
+3.95 (+4.10%)
At Close: Jun 03, 2026
BEDFORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clini
Why Lantheus Holdings Stock Popped by Almost 12% Last Month
04:43pm, Monday, 09'th Mar 2026
Although its adjusted net income dipped, it handily beat analyst expectations on both the top and bottom lines. It also announced a very sensible pivot in its business.
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
04:01pm, Friday, 06'th Mar 2026
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines the diagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for larger batches and greater p
Elo Mutual Pension Insurance Co Acquires New Stake in Lantheus Holdings, Inc. $LNTH
04:00am, Friday, 06'th Mar 2026
Elo Mutual Pension Insurance Co bought a new position in shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) during the undefined quarter, according to the company in its most recent disclosure with the
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has
Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript
07:47pm, Thursday, 26'th Feb 2026
Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
07:00am, Thursday, 26'th Feb 2026
BEDFORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to
Lantheus to Present at March 2026 Investor Conferences
08:30am, Tuesday, 24'th Feb 2026
BEDFORD, Mass. , Feb. 24, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick and Foti, LLC ("KSF"), announces that
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
08:00am, Thursday, 12'th Feb 2026
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has comme
A New Nuclear Materials Rush Is Underway and Wall Street Is Starting to Notice
09:49am, Tuesday, 27'th Jan 2026
In 1979, the Three Mile Island nuclear power plant suffered a partial nuclear meltdown.
Stanley Laman Group Ltd. Acquires 22,229 Shares of Lantheus Holdings, Inc. $LNTH
07:04am, Monday, 05'th Jan 2026
Stanley Laman Group Ltd. raised its holdings in Lantheus Holdings, Inc. (NASDAQ: LNTH) by 38.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stock Position in Lantheus Holdings, Inc. $LNTH
05:08am, Monday, 05'th Jan 2026
VIRGINIA RETIREMENT SYSTEMS ET Al cut its stake in Lantheus Holdings, Inc. (NASDAQ: LNTH) by 36.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The in
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
08:00am, Friday, 02'nd Jan 2026
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping cli
Sign In
Buy LNTH